ZYME
Zymeworks Inc.Company with tickers: ZYME
CIK
1937653
Shares Outstanding
73,749,607
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-02-01 | Mekan Sabeen | SVP & Chief Medical Officer | Other | 0 |
| 2026-02-01 | Mekan Sabeen | SVP & Chief Medical Officer | Other | 0 |
| 2026-02-01 | Mekan Sabeen | SVP & Chief Medical Officer | Other | 0 |
| 2026-02-01 | Mekan Sabeen | SVP & Chief Medical Officer | Other | 0 |
| 2026-01-12 | Hollywood Mark | EVP & Chief Operating Officer | Convert | 17,666 |
| 2026-01-12 | Hollywood Mark | EVP & Chief Operating Officer | Convert | 17,666 |
| 2026-01-12 | Hollywood Mark | EVP & Chief Operating Officer | Award | 47,000 |
| 2026-01-12 | Cherry Brian N | Director | Other | 0 |
| 2026-01-12 | Cherry Brian N | Director | Award | 23,000 |
| 2026-01-12 | Cherry Brian N | Director | Award | 15,400 |
| 2026-01-12 | Galbraith Kenneth | Director, Chair & CEO | Convert | 64,000 |
| 2026-01-12 | Hollywood Mark | EVP & Chief Operating Officer | Award | 66,000 |
| 2026-01-12 | Hollywood Mark | EVP & Chief Operating Officer | Sell | 6,120 |
| 2026-01-12 | Hollywood Mark | EVP & Chief Operating Officer | Award | 70,000 |
| 2026-01-12 | Landry Robert E | Director | Award | 11,500 |
| 2026-01-12 | Landry Robert E | Director | Award | 7,700 |
| 2026-01-12 | Cesano Alessandra | Director | Award | 7,700 |
| 2026-01-12 | Cesano Alessandra | Director | Award | 11,500 |
| 2026-01-12 | Campoy Carlos | Director | Award | 7,700 |
| 2026-01-12 | Campoy Carlos | Director | Award | 11,500 |
| 2026-01-12 | Mahony Susan | Director | Award | 7,700 |
| 2026-01-12 | Mahony Susan | Director | Award | 11,500 |
| 2026-01-12 | Galbraith Kenneth | Director, Chair & CEO | Award | 216,000 |
| 2026-01-12 | Galbraith Kenneth | Director, Chair & CEO | Award | 222,000 |
| 2026-01-12 | Moore Paul Andrew | Chief Scientific Officer | Convert | 17,666 |
| 2026-01-12 | Moore Paul Andrew | Chief Scientific Officer | Sell | 9,560 |
| 2026-01-12 | Moore Paul Andrew | Chief Scientific Officer | Award | 70,000 |
| 2026-01-12 | Moore Paul Andrew | Chief Scientific Officer | Award | 66,000 |
| 2026-01-12 | Moore Paul Andrew | Chief Scientific Officer | Award | 47,000 |
| 2026-01-12 | Moore Paul Andrew | Chief Scientific Officer | Convert | 17,666 |
| 2026-01-12 | Smith Jeffrey T L | EVP & Chief Medical Officer | Convert | 17,666 |
| 2026-01-12 | Smith Jeffrey T L | EVP & Chief Medical Officer | Sell | 9,310 |
| 2026-01-12 | Smith Jeffrey T L | EVP & Chief Medical Officer | Convert | 17,666 |
| 2026-01-12 | Galbraith Kenneth | Director, Chair & CEO | Convert | 64,000 |
| 2026-01-12 | Ciongoli Gregory Austin | Director | Award | 7,700 |
| 2026-01-12 | Ciongoli Gregory Austin | Director | Award | 11,500 |
| 2026-01-12 | Neu Kelvin | Director | Award | 11,500 |
| 2026-01-12 | Neu Kelvin | Director | Award | 7,700 |
| 2026-01-12 | Galbraith Kenneth | Director, Chair & CEO | Sell | 30,424 |
| 2026-01-12 | Galbraith Kenneth | Director, Chair & CEO | Award | 144,000 |
| 2026-01-09 | Hollywood Mark | EVP & Chief Operating Officer | Other | 0 |
| 2026-01-09 | Hollywood Mark | EVP & Chief Operating Officer | Other | 0 |
| 2026-01-09 | Hollywood Mark | EVP & Chief Operating Officer | Other | 121,367 |
| 2026-01-06 | PATTERSON LEONE D | EVP, Chief Bus & Fin Officer | Award | 459 |
| 2026-01-05 | Galbraith Kenneth | Director, Chair & CEO | Convert | 47,668 |
| 2026-01-05 | Moore Paul Andrew | Chief Scientific Officer | Sell | 9,289 |
| 2026-01-05 | Moore Paul Andrew | Chief Scientific Officer | Convert | 17,168 |
| 2026-01-05 | Moore Paul Andrew | Chief Scientific Officer | Convert | 17,168 |
| 2026-01-05 | Galbraith Kenneth | Director, Chair & CEO | Convert | 47,668 |
| 2026-01-05 | Smith Jeffrey T L | EVP & Chief Medical Officer | Convert | 20,000 |
| 2026-01-05 | Smith Jeffrey T L | EVP & Chief Medical Officer | Convert | 20,000 |
| 2026-01-05 | Galbraith Kenneth | Director, Chair & CEO | Sell | 22,657 |
| 2026-01-05 | Smith Jeffrey T L | EVP & Chief Medical Officer | Sell | 10,538 |
| 2025-12-22 | Galbraith Kenneth | Director, Chair & CEO | Convert | 100,000 |
| 2025-12-22 | Galbraith Kenneth | Director, Chair & CEO | Sell | 47,528 |
| 2025-12-22 | Galbraith Kenneth | Director, Chair & CEO | Convert | 100,000 |
| 2025-08-12 | Ciongoli Gregory Austin | Director | Award | 415,000 |
| 2025-08-11 | Ciongoli Gregory Austin | Director | Award | 62,000 |
| 2025-08-11 | Landry Robert E | Director | Award | 62,000 |
| 2025-08-11 | Ciongoli Gregory Austin | Director | Other | 5,000 |
| 2025-08-10 | Ciongoli Gregory Austin | Director | Other | 73,500 |
| 2025-08-10 | Landry Robert E | Director | Other | 0 |
| 2025-08-10 | Ciongoli Gregory Austin | Director | Other | 0 |
| 2025-06-26 | EcoR1 Capital, LLC | Director, 10% Owner | Tax | 41 |
| 2025-06-26 | EcoR1 Capital, LLC | Director, 10% Owner | Exercise | 5,086,480 |
| 2025-06-26 | EcoR1 Capital, LLC | Director, 10% Owner | Exercise | 5,086,521 |
| 2025-05-19 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 5,919 |
| 2025-05-15 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 49,502 |
| 2025-04-17 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 54,760 |
| 2025-04-16 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 73,953 |
| 2025-04-04 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 196,438 |
| 2025-04-03 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 120,770 |
| 2025-04-02 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 74,360 |
| 2025-04-01 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 48,658 |
| 2025-03-31 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 4,397 |
| 2025-03-26 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 43,848 |
| 2025-03-25 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 53,501 |
| 2025-03-24 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 22,689 |
| 2025-03-21 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 31,033 |
| 2025-03-20 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 73,476 |
| 2025-03-19 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 58,306 |
| 2025-03-18 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 113,880 |
| 2025-03-17 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 56,277 |
| 2025-03-13 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 468,356 |
| 2025-03-12 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 292,934 |
| 2025-03-11 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 320,690 |
| 2025-02-17 | NODELMAN OLEG | Director, 10% Owner | Other | 15,720,161 |
| 2025-02-17 | NODELMAN OLEG | Director, 10% Owner | Other | 0 |
| 2025-01-17 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 19,748 |
| 2025-01-16 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 121,681 |
| 2025-01-15 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 39,029 |
| 2025-01-14 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 54,500 |
| 2025-01-13 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 74,125 |
| 2025-01-10 | PATTERSON LEONE D | EVP, Chief Bus & Fin Officer | Award | 79,000 |
| 2025-01-10 | PATTERSON LEONE D | EVP, Chief Bus & Fin Officer | Award | 53,000 |
| 2025-01-10 | Moore Paul Andrew | Chief Scientific Officer | Award | 79,000 |
| 2025-01-10 | Smith Jeffrey T L | EVP & Chief Medical Officer | Award | 79,000 |
| 2025-01-10 | Smith Jeffrey T L | EVP & Chief Medical Officer | Award | 53,000 |
| 2025-01-10 | Moore Paul Andrew | Chief Scientific Officer | Award | 53,000 |
| 2025-01-10 | EcoR1 Capital, LLC | Director, 10% Owner | Buy | 204,098 |